💼 Have institutional investors recently increased their holdings in healthcare stocks?

There is no available data that institutional investors have recently increased their holdings in healthcare stocks. However, we can infer that some institutional investors may have increased their holdings in healthcare stocks based on the following analysis: 1. **Recent Investments by Leading Healthcare-Focused Investment Firms**: - **OrbiMed** has raised $1.86 billion for its healthcare royalty and credit fund, indicating its continued focus on investing in healthcare companies. - **MVM Partners** led an $80 million series B financing for ProVerum, a company developing a minimally invasive solution for benign prostatic hyperplasia (BPH), showcasing their investment in disruptive healthcare products. - **ClearBridge Health** announced a USD 131 million pre-IPO financing, highlighting their commitment to advancing clinical programs and global expansion in the healthcare sector. 2. **Institutional Interest in Specific Healthcare Stocks**: - **Sabra Healthcare REIT** reported better-than-expected EPS and set its FY 2025 guidance, which may indicate institutional confidence in the company's performance. - **Molecular Partners** has secured funding into 2028, highlighting its strong market positioning and potential for growth. - **RNA Stock** has seen a significant increase due to acquisition rumors with Novartis, which may reflect institutional interest in the company's potential value. 3. **Market Trends and Sector Growth**: - The healthcare sector is projected to grow at a robust compound annual growth rate (CAGR) of 9.07% until 2032, reaching a size of $44.7 trillion, primarily driven by an aging population and technological advancements. - The global healthcare data monetization market is anticipated to grow from USD 0.58 billion in 2025 to USD 1.16 billion by 2030, reflecting a CAGR of 14.9% during the forecast period. While these points suggest that institutional investors are actively investing in healthcare and related sectors, there is no specific data indicating an overall increase in holdings by institutional investors in healthcare stocks. Institutional investments are likely to be sector-specific and based on individual company performance and growth potential.